Adam R. Craig is CEO & President at CTI BIOPHARMA CORP (CTIC). They have made 10 open-market trades across 2 companies since 2014, most recently 2026-08-12.
CIK 0001339498
3 open-market purchases totalling $533K since 2021, against 7 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| XFOR | 328,651 | $851K |
| SNSS | 23,452 | $437K |
| CTIC | 29,440 | $268K |
| IVPH.OB | 17,120 | — |
| Total | $1.6M |
Shares reported on the most recent Form 4, priced at the 2026-08-13 close. 1 holding could not be priced and is excluded from the total.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| XFOR | SELL | 2026-08-12 | 2026-08-13 | $4.44 | $211K | -1.4% | -13.8% | — |
| XFOR | BUY | 2025-10-23 | 2025-10-27 | $2.90 | $500K | -11.3% | -7.8% | -8.1% |
| CTIC | SELL | 2023-01-24 | 2023-01-26 | $6.00 | $512K | -2.3% | -3.9% | -13.2% |
| CTIC | SELL | 2022-12-29 | 2023-01-03 | $6.01 | $1.2M | -0.9% | -1.9% | -26.6% |
| CTIC | SELL | 2022-11-09 | 2022-11-14 | $6.00 | $1.6M | -4.5% | -3.1% | -13.4% |
| CTIC | SELL | 2022-09-12 | 2022-09-14 | $6.43 | $1.6M | -11.7% | -26.8% | -6.4% |
| CTIC | BUY | 2022-08-16 | 2022-08-16 | $5.50 | $28K | +21.2% | +17.0% | +12.5% |
| CTIC | SELL | 2022-07-01 | 2022-07-06 | $6.04 | $547K | +3.3% | +22.8% | +0.3% |
| CTIC | SELL | 2022-06-01 | 2022-06-03 | $6.00 | $543K | -1.9% | +6.3% | +10.2% |
| CTIC | BUY | 2021-12-02 | 2021-12-02 | $1.53 | $5K | +37.3% | +62.7% | +120.3% |
| SNSS | SELL · 10b5-1 | 2014-08-27 | 2014-08-29 | $8.00 | $20K | -0.0% | +1.2% | +1.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.